Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.

ABSTRACT:

Importance

The association of guideline-based decision support with the quality of care in patients with non-small cell lung cancer (NSCLC) is not known.

Objective

To evaluate the association of exposure to the National Comprehensive Cancer Center (NCCN) guidelines with guideline-concordant care and patients' decisional conflict.

Design, setting, and participants

A nonrandomized clinical trial, conducted at a tertiary care academic institution, enrolled patients from February 23, 2015, to September 28, 2017. Data analysis was conducted from July 19, 2019, to April 22, 2020. A cohort of 76 patients with NSCLC seen at diagnosis or disease progression and a retrospective cohort of 157 patients treated before the trial were included. Adherence to 6 NCCN recommendations we

SUBMITTER: Wu SY 

PROVIDER: S-EPMC7527870 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature